Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii (Q36015869)

11 August 2017

1 reference

title

Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii (English)

1 reference

11 August 2017

0 references

0 references

Julio Aliberti

1

1 reference

11 August 2017

1 February 2005

1 reference

Nature Reviews Immunology

11 August 2017

1 reference

11 August 2017

5

1 reference

11 August 2017

2

1 reference

11 August 2017

162-170

1 reference

Lytic cycle of Toxoplasma gondii

11 August 2017

1 reference

The neuropathology and epidemiology of AIDS. A Berlin experience. A review of 200 cases

21 January 2018

1 reference

From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii

21 January 2018

1 reference

In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas

21 January 2018

1 reference

Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells

21 January 2018

1 reference

Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondii.

21 January 2018

1 reference

Structural determinants of the anti-HIV activity of a CCR5 antagonist derived from Toxoplasma gondii.

21 January 2018

1 reference

Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells.

21 January 2018

1 reference

Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction

21 January 2018

1 reference

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

TRAF6-dependent mitogen-activated protein kinase activation differentially regulates the production of interleukin-12 by macrophages in response to Toxoplasma gondii

21 January 2018

1 reference

Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function

21 January 2018

1 reference

Complement and IL-12: yin and yang.

21 January 2018

1 reference

Molecular cloning and characterization of peroxiredoxin from Toxoplasma gondii

21 January 2018

1 reference

Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV.

21 January 2018

1 reference

Poxvirus interference with the host cytokine response.

21 January 2018

1 reference

Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators

21 January 2018

1 reference

Interleukin-10 downregulates the intracerebral immune response in chronic Toxoplasma encephalitis.

21 January 2018

1 reference

Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity

21 January 2018

1 reference

Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease

21 January 2018

1 reference

Lipoxins: pro-resolution lipid mediators in intestinal inflammation

21 January 2018

1 reference

Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases

21 January 2018

1 reference

Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo

21 January 2018

1 reference

Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis

21 January 2018

1 reference

A stable aspirin-triggered lipoxin A4 analog blocks phosphorylation of leukocyte-specific protein 1 in human neutrophils

21 January 2018

1 reference

Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor

21 January 2018

1 reference

Lipoxin A4: a new class of ligand for the Ah receptor

21 January 2018

1 reference

Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense.

21 January 2018

1 reference

15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure

21 January 2018

1 reference

The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response

21 January 2018

1 reference

The SOCS box: a tale of destruction and degradation

21 January 2018

1 reference

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

21 January 2018

1 reference

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

21 January 2018

1 reference

Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection

21 January 2018

1 reference

Lipoxygenase genes and their targeted disruption

21 January 2018

1 reference

Exogenous pathogen and plant 15-lipoxygenase initiate endogenous lipoxin A4 biosynthesis

21 January 2018

1 reference

Lipid mediator class switching during acute inflammation: signals in resolution.

21 January 2018

1 reference

The opportunistic pathogen Pseudomonas aeruginosa carries a secretable arachidonate 15-lipoxygenase

21 January 2018

1 reference

Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway

21 January 2018

1 reference

The immunological aspects of latency in tuberculosis

21 January 2018

1 reference

Immune evasion by Mycobacterium tuberculosis: living with the enemy

21 January 2018

1 reference

CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells

21 January 2018

1 reference

ICSBP/IRF-8 retrovirus transduction rescues dendritic cell development in vitro

21 January 2018

1 reference

Paralysis of Dendritic Cell IL-12 Production by Microbial Products Prevents Infection-Induced Immunopathology

21 January 2018

1 reference

Interleukin-10 does not contribute to the pathogenesis of a virulent strain of Toxoplasma gondii

21 January 2018

1 reference

IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii

31 March 2020

1 reference

Cutting Edge: Lipoxin (LX) A4 and Aspirin-Triggered 15-Epi-LXA4 Block Allergen-Induced Eosinophil Trafficking

31 March 2020

1 reference

Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRI1547

1 reference

11 August 2017

1 reference

PubMed ID

15662369